Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and atenolol

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with atenolol in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(atenolol)		Trials
(atenolol)		Recent Studies (post-2010) (atenolol)
9,1561875525,4731,950852

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)atenolol (IC50)
Beta-1 adrenergic receptorHomo sapiens (human)0.7468
Alpha-1D adrenergic receptorHomo sapiens (human)0.23
Alpha-1A adrenergic receptorHomo sapiens (human)0.23
Alpha-1B adrenergic receptorHomo sapiens (human)0.23

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demopoulos, CA; Kapoulas, VM; Tsangaris, GT; Tsoukatos, DC1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and atenolol

ArticleYear
Study of the glycogenolytic action of platelet activating factor in Tetrahymena pyriformis.
    Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 1992, Volume: 102, Issue:3

    Topics: Animals; Atenolol; Calcium; Cyclic AMP; Glucose; Glycogen; Labetalol; Platelet Activating Factor; Propranolol; Tetrahymena pyriformis

1992